Malaria Vaccines 101
Explore the complexities of malaria vaccine development, targeting Plasmodium species/stages, immunity evidence, and broad vaccine approaches focusing on sub-unit vaccines. Discover the quest for an effective and accessible malaria vaccine.
9 views • 32 slides
Latest COVID-19 Update & Vaccination Guidelines - January 18, 2024
The update covers key messages on COVID-19 vaccination, the Novavax vaccine, and treatment options for COVID cases. Vaccination is recommended for individuals above four years old with updated vaccines available since September 12, 2023. Novavax is a protein subunit vaccine that triggers the immune
2 views • 9 slides
Addressing Health Inequalities and Vaccine Hesitancy in Shirebrook: Findings and Strategies
Shirebrook, a deprived area in Derbyshire, has been grappling with health inequalities and vaccine hesitancy, particularly among certain groups like ethnic minorities and those living in deprivation. Efforts have been made to engage the community, resulting in varying levels of vaccine uptake among
1 views • 14 slides
Update on Infectious Disease Prevention and H5N1 Vaccine Production
This content provides updates on infectious disease prevention efforts, including historical data, TB data posting schedule, and HIV surveillance updates. It also highlights the plans of the US Department of Health and Human Services to produce 4.8 million doses of the H5N1 avian flu vaccine for pan
0 views • 7 slides
Understanding Polio Eradication Efforts and Vaccine Development
Polio, a disabling disease caused by the poliovirus, mainly affects children and can lead to paralysis. Efforts to eradicate polio include the development of vaccines like the Inactivated Polio Vaccine (IPV) and Oral Polio Vaccine (OPV). The poliovirus' choice of host, ease of transmission, and impa
0 views • 15 slides
Moderna Becomes Third Covid Vaccine Approved in the UK - Important Updates
The UK has approved Moderna as the third Covid vaccine, with logistical challenges due to required storage at -75C. AstraZeneca's vaccine is easier to distribute. Moderna offers nearly 95% protection from severe Covid, but all vaccines require a second dose for optimal immunity. Uncertainty remains
0 views • 7 slides
National COVID-19 Vaccine Deployment and Roll-Out Plan in Zimbabwe
The Republic of Zimbabwe is gearing up for the introduction of a COVID-19 vaccine as part of its response to the pandemic, with a focus on deploying 200,000 doses to priority groups. The comprehensive plan includes key strategies, financing alignment, and integration into national governance mechani
5 views • 28 slides
COVID-19 Update and Vaccine Booster Recommendations - June 15, 2023
Stay informed with the latest COVID-19 update as of June 15, 2023. Explore vaccine booster recommendations to safeguard your health and well-being. Access a series of informative slides illustrating key points related to COVID-19 and the booster shot guidelines. Stay protected and be proactive in co
0 views • 9 slides
Utilising Social Prescribers to Address Vaccine Cautiousness in London
London is prioritizing vaccine uptake and tackling cautiousness by leveraging the expertise of Personalised Care roles and Social Prescribing Link Workers. This event highlights innovative approaches and best practices to engage vulnerable communities, provide support, and address concerns around CO
0 views • 12 slides
Understanding Vaccine Safety, Effectiveness, and Side Effects: A Guide to Better Living
This informative content delves into vaccine safety, effectiveness, and side effects, offering insights into the development stages of vaccines, COVID-19 vaccine comparisons, and an overview of COVID-19 vaccine development. It also explains how vaccines work to protect against viruses and emphasizes
0 views • 33 slides
Potential Pyogenic Liver Abscess Case Report in Elderly Female Post COVID-19 Vaccination
An 84-year-old female presented with fever, SOB, fatigue, and diarrhea after receiving a COVID-19 vaccine. Despite initial improvement with antibiotics, she developed liver abscess, highlighting the complexity of diagnosing post-vaccination symptoms. Clinicians should remain vigilant and consider al
0 views • 5 slides
COVID-19 Vaccine Update: Pfizer Vaccine Logistics and Emergency Use Authorization
The update discusses the latest information on Pfizer's COVID-19 vaccine, including details on the new technology, storage requirements, logistics handling, and Emergency Use Authorization (EUA). Pfizer's vaccine, with a 95% efficacy rate, requires storage in ultra-low-temperature freezers or therma
0 views • 28 slides
Co-created Messages & Trusted Messengers for COVID-19 Vaccine Acceptance in Northern Nigeria
Dr. Chizoba Wonodi is evaluating the use of co-created messages and trusted messengers to improve COVID-19 vaccine acceptance in Northern Nigeria. Vaccine hesitancy due to conspiracy theories and safety concerns remains a challenge. TM-COVAC study aims to design targeted messages using human-centere
0 views • 8 slides
VASE+ Release 11.4: New Features for Vaccine Management
In the latest VASE+ Release 11.4, several new features have been introduced to enhance vaccine management processes. These include a new vaccine selection field, Pfizer vaccine lot addition for 5-11-year-olds, color coding per vaccine type, customizability options, new columns for vaccine name and s
0 views • 8 slides
Vaccine Administration Best Practices and Waste Management
This content provides valuable information on handling vaccines, including determining vaccine viability, identifying wastage, and understanding expiration dates. It includes scenarios covering vaccine storage, reporting spoiled doses, and managing vial wastage. The answers and explanations offered
0 views • 7 slides
Interrogating the Establishment of Vaccine Plants in Africa: Case Studies of Rwanda and Uganda
Nimrod Muhumuza, from Afya na Haki Institute, presents a critical analysis of vaccine plant setup in Rwanda and Uganda. The discussion focuses on the potential leadership roles of small economies, private sector involvement, sustainability of vaccine production, and the importance of participation f
0 views • 13 slides
Effect of Efgartigimod on Humoral Vaccine Responses in Patients with Autoimmune Diseases
The study explores the impact of Efgartigimod, a Neonatal Fc Receptor blocker, on humoral vaccine responses in patients with autoimmune diseases. It discusses how immunosuppressive therapies used in autoimmune disorders may affect susceptibility to infections and impair vaccine immunogenicity, highl
0 views • 18 slides
Understanding the COVID-19 Vaccine: Information from Illinois Department of Corrections
The Illinois Department of Corrections emphasizes the importance of the COVID-19 vaccine, highlighting its effectiveness in preventing severe illness. Individuals are encouraged to make an informed decision about vaccination, ensuring protection for themselves and others. The department assures that
0 views • 52 slides
Understanding the Oxford-AstraZeneca Vaccine: Benefits, Risks, and Recommendations
The Oxford-AstraZeneca vaccine has shown a likely but unproven link to cerebral venous sinus thrombus and other blood clotting issues. Despite this, the benefits of vaccination still outweigh the risks, with only approximately 4 cases per million resulting in death. Communication of the potential be
0 views • 10 slides
Update on COVID-19 Vaccine Uptake in Tennessee as of October 8, 2021
In this update, Tennessee reports an increase in COVID-19 vaccine uptake with 52.8% having at least one dose and 46.7% fully immunized. The state ranks 40th in vaccine administration per 100K population. Vaccine hesitancy is addressed, and dates of FDA committee meetings on booster authorizations an
0 views • 15 slides
History of Vaccine Liability and Legal Issues in the United States
This presentation discusses the history of vaccine liability and legal battles in the United States, covering events such as the Cutter Incident, the Swine Flu vaccine campaign, and cases like Berkovitz v. U.S. It explores the challenges, consequences, and legal defenses surrounding vaccine-related
0 views • 25 slides
Michigan COVID-19 Vaccine Survey Insights
The Michigan COVID-19 Survey conducted in March 2021 provides valuable insights on vaccine segments, key findings, and likelihood to get the vaccine among residents aged 16 and older. The survey categorizes individuals into Vaccine Definites, Persuadables, and Nevers, highlighting that 61% are firml
1 views • 10 slides
Covid Confidence DWB Volunteer Session: Supporting Community with Covid Information
Empower volunteers with information on Covid issues, vaccines, testing, and myth-busting. Engage in discussions, share vaccine info, and address concerns around vaccine rollout and safety. Understand mRNA vaccines, testing speed, and safety measures in trials.
0 views • 15 slides
Oregon Department of Education - COVID-19 Vaccines for Ages 5-11 Information
Learn about the COVID-19 vaccines for children ages 5-11 as presented by the Oregon Department of Education. Discover essential information, such as vaccine availability, dosage, effectiveness, and the importance of vaccination to protect your child's health and well-being. Find out how school leade
0 views • 6 slides
Impact of COVID-19 on Food Systems & Rural Livelihoods in Malawi
Study in Malawi reveals perceptions on COVID-19, with high awareness but varied beliefs regarding the disease, health services, and vaccine acceptance. Challenges include misconceptions, reluctance to seek medical care, and low vaccine uptake in rural areas. The research aims to investigate the effe
0 views • 19 slides
Vaccine Inventory Lot Management Job Aid
This job aid explains how Site Admins can add, edit, and manage vaccine inventory lots for clinics. Users can add new vaccine lots, edit existing entries, and associate vaccine lots with specific clinics in the system. The process involves entering lot details, NDC code, expiration, and available do
0 views • 4 slides
Global Vaccine and Immunization Research Forum 2023 Agenda
The Global Vaccine and Immunization Research Forum 2023, scheduled for March 28-30 at Grand Hyatt, Incheon, Korea, will feature keynote speakers, plenary sessions, workshops, and discussions on various topics related to vaccine research, development, and global health. The agenda includes sessions o
0 views • 9 slides
COVID-19 Vaccination for People Experiencing Homelessness Presentation Overview
This presentation, developed by CDC's COVID-19 Response Vaccine Task Force and Homelessness Unit, focuses on COVID-19 vaccination basics, safety, prioritization for individuals experiencing homelessness, and strategies to overcome barriers to vaccination. It highlights the importance of understandin
0 views • 49 slides
Salivary Gustin and Taste Dysfunction in Long-COVID Patients
The research explores the association between taste perception and the duration of COVID infection in long-COVID and COVID-reinfection cases. Reduced salivary gustin levels correlated with lower taste scores in long-COVID patients. The study also found an increase in the bitter taste receptor gene e
1 views • 4 slides
London Care Home Flu Vaccine Campaign Pack 20/21
This campaign pack provides resources for care home providers in London to increase flu vaccine uptake among staff. It includes key messages, strategies, and tools tailored for engaging with healthcare and social care staff, emphasizing the importance of flu vaccination in light of the COVID-19 pand
0 views • 21 slides
Key Takeaways from KFF COVID-19 Vaccine Monitor April 2021
Vaccine confidence has increased among the public as more people see friends and family members vaccinated. Demographics show varying attitudes towards COVID-19 vaccines, with concerns including access and misinformation. Health care providers are trusted messengers for vaccine information, especial
0 views • 7 slides
COVID-19 Vaccine Updates and Recommendations - January 2023
New updates regarding COVID-19 vaccine administration and recommendations have been released, including the ability for clinics to create and manage vaccine supplies for children as young as six months. The Western States Scientific Review Workgroup supports the use of Moderna and Pfizer-BioNTech bi
0 views • 6 slides
COVID-19 Vaccine Provider Call Updates July 2022
Updates on COVID-19 vaccine distribution and administration in Oklahoma, including the number of doses administered, individuals partially and fully vaccinated, and guidance on booster doses and addressing vaccine hesitancy. The data reflects information as of June 21, 2022. Highlights include the t
0 views • 40 slides
Clearing Misconceptions: COVID-19 Vaccine Presentation for Post-Acute & Long-Term Care
Addressing common concerns and questions regarding the COVID-19 vaccine in a presentation tailored for staff and residents in post-acute and long-term care facilities. Topics include vaccine safety, effectiveness, the mRNA technology, emergency use authorization, protection duration, and reasons for
0 views • 20 slides
NC COVID-19 Vaccine Plan Update Oct 9, 2020 Task Force Meeting Overview
The NC COVID-19 Vaccine Plan discussed in the October 9, 2020 Task Force Meeting includes details on vaccine supply, distribution goals, clinical trial timelines, safety, and outreach strategies. Key points cover vaccine development progress, trial protocols, distribution targets, and communication
0 views • 6 slides
Safety and Efficacy of BNT162b2 mRNA Covid-19 Vaccine Phase 3 Data
Phase 3 data of the BNT162b2 mRNA Covid-19 vaccine, including study design, participant groups, primary endpoints, and key findings regarding safety and efficacy. The vaccine demonstrated efficacy against confirmed Covid-19, with reported local and systemic adverse effects within a specified timefra
0 views • 48 slides
Aging and Disability Vaccine Collaborative (ADVC) Project Overview
The Aging and Disability Vaccine Collaborative (ADVC) led by Tannis Hargrove at the University of Montana aims to support vaccination education and promotion activities for older adults and people with disabilities. Through partnerships with various organizations, the ADVC provides accessible and in
0 views • 12 slides
Introduction of Gardasil HPV Vaccine in Sikkim's Routine Immunization Programme
Cervical cancer is a major health issue in Sikkim, India, prompting the introduction of the Gardasil HPV vaccine to address the high prevalence of HPV infections leading to cervical cancer. The state-wide immunization campaign targeted girls aged 9-14, aiming to incorporate the vaccine into the rout
0 views • 10 slides
COVID-19 Communication Strategy: Tackling the Fourth Wave Together
Amid the challenges in reaching vaccine targets and combating COVID-19 misinformation, a comprehensive communication strategy is outlined. Through the production of infographics, videos, and workshops in multiple languages, the focus is on promoting credible information and encouraging non-pharmaceu
0 views • 15 slides
Permutation Tests and False Detection Rate in HPV Vaccine Trial
Permutation tests are computer-intensive methods used for hypothesis testing when the distribution of the test statistic is unknown. In a hypothetical HPV vaccine trial with 200 women, the scientific question revolves around comparing infection risks in groups receiving the vaccine and placebo. The
0 views • 19 slides